Breaking News
August 20, 2018 - Primary Care Provider Burnout Rate Low in Small Practices
August 20, 2018 - Discovery presents treatment hope for Alzheimer’s and other neurodegenerative diseases
August 20, 2018 - Stroke patients appear to receive better care at teaching hospitals with less chance of readmission
August 20, 2018 - Distinct origin of ADHD identified In children with history of traumatic brain injury
August 20, 2018 - AHA: Wildfire Smoke Threatens Health of Those Near and Far
August 20, 2018 - Here’s a mental health workout that’s as simple as ABC
August 20, 2018 - Newly discovered cytoskeleton utilized by cancer cells for survival
August 19, 2018 - Bifidobacteria supplement colonizes gut of breastfed infants
August 19, 2018 - Why patients with Alzheimer’s markers never develop the condition
August 19, 2018 - ACA’s Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment
August 19, 2018 - Important factor may be missing in models used to predict spread of epidemics from climate change
August 19, 2018 - Indian-Americans have fewer sudden infant deaths, study finds
August 19, 2018 - Experts advise against universal genomic screening of newborns
August 19, 2018 - New trial to investigate whether weight loss before conception can make mom and baby healthier
August 19, 2018 - Sun Pharma Announces FDA Approval of Cequa (cyclosporine) Ophthalmic Solution to Treat Dry Eye Disease
August 19, 2018 - Researchers examining Parkinson’s resilience
August 19, 2018 - HPI, INTEGRIS and USPI enter into agreement to offer patients more choice, flexibility of care
August 19, 2018 - Researchers find mechanism that prepares brain to replicate repeated actions
August 19, 2018 - Those who are emotionally stable when young may remain the most stable as they age
August 19, 2018 - URI professor develops simpler and quicker method for detecting impurity in heparin
August 19, 2018 - Mayo Medical Laboratories and NDSC collaborate to develop new patient blood-management solution
August 19, 2018 - Insight into endocrine cancers and treatment options
August 19, 2018 - HPV Legislation Doesn’t Impact Teen Sexual Behaviors
August 19, 2018 - Exenatide treatment alleviated symptoms of depression in patients
August 19, 2018 - Tufts researchers win grant to study integration of genomic sequencing into neonatal care
August 19, 2018 - Novel finger-prick test can help prevent toxoplasmosis
August 19, 2018 - Cosmetic Procedures Boost Well-Being, Poll Shows
August 19, 2018 - Responsive parenting intervention results in lower BMIs through age three
August 19, 2018 - Anticancer drugs can help plants to battle infection
August 19, 2018 - Sunscreen from bathers releases significant quantities of polluting titanium dioxide into the sea
August 19, 2018 - Case Western Reserve gets three-year grant to enhance food systems in Cleveland neighborhoods
August 19, 2018 - Teenagers can thank their parents’ positive attitude for avoiding obesity
August 19, 2018 - Body mass index positively linked with blood pressure
August 19, 2018 - New tool fills gap in Small Molecules market
August 19, 2018 - Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials
August 19, 2018 - Researchers develop molecular matrix that delivers healing stem cells to injured elderly muscles
August 19, 2018 - Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
August 19, 2018 - New study pinpoints ways to improve quality of food and nutrition research
August 19, 2018 - Ology Bioservices wins $8.4 million worth agreement to manufacture anti-Ebola monoclonal antibody
August 19, 2018 - New CRISPR technology may help eliminate mutated gene sequence
August 19, 2018 - “Zombie gene” protects elephants from cancer finds study
August 19, 2018 - Study explores how many American cities protect the rights of employed breastfeeding mothers
August 19, 2018 - FDA Approves Lenvima (lenvatinib) for First-line Treatment of Unresectable Hepatocellular Carcinoma (HCC)
August 19, 2018 - Pain: Considering Complementary Approaches (eBook)
August 19, 2018 - Autoimmune response drives vision loss in glaucoma
August 19, 2018 - Tandem Diabetes Care introduces t:slim X2 Insulin Pump with Basal-IQ Technology in the US
August 19, 2018 - Innovative platform developed to destroy cancer cells
August 19, 2018 - Lowering pH inside tumor cells can slow down spread of cancer
August 19, 2018 - Biomarker predicts kidney cancer risk years before diagnosis
August 19, 2018 - Consequences of healthcare-associated infections go beyond patients’ physical health
August 19, 2018 - New drug- free, nanotechnology-based method detects and treats oral plaque
August 19, 2018 - Integration of Opioid, Infectious Disease Treatment Needed
August 19, 2018 - How eye disorders may have influenced the work of famous painters
August 18, 2018 - Blood biomarker could help predict kidney cancer up to five years prior to diagnosis
August 18, 2018 - Dartmouth scientists create more sustainable feed for aquaculture
August 18, 2018 - Immigrants Not a Burden on U.S. Health Care: Study
August 18, 2018 - Women who eat fast food take longer to become pregnant
August 18, 2018 - Most YouTube videos on plastic surgery are misleading marketing campaigns
August 18, 2018 - The essential guide to make your laboratory more sustainable
August 18, 2018 - Loyola Medicine offers scalp cooling treatment to reduce risk of chemotherapy hair loss
August 18, 2018 - Researchers describe promising strategy to remove melanoma’s most powerful defenses
August 18, 2018 - Women with polycystic ovary syndrome dissatisfied with medical care
August 18, 2018 - Research discoveries reveal insights behind neurological degeneration
August 18, 2018 - Researchers win multi-million Euro award to conduct research into liver disease
August 18, 2018 - Survey highlights variations in practice of airway management in pediatric intensive care units
August 18, 2018 - UK students win sponsorship from Promega Corporation
August 18, 2018 - Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the treatment of HIV-1
August 18, 2018 - PSD as a molecular platform for understanding synapse formation and plasticity
August 18, 2018 - Improved visual communication could help patients to make informed health-care decisions
August 18, 2018 - New algorithm helps identify and manage diabetic patients at increased fracture risk
August 18, 2018 - Microscopic insect odour detecting mechanisms discovered
August 18, 2018 - Researchers develop new approach to study how tuberculosis infects people
August 18, 2018 - FDA Approves Kalydeco (ivacaftor) for Cystic Fibrosis in Children Ages 12 to
August 18, 2018 - An ion channel differentiates newborn and mature neurons in the adult brain
August 18, 2018 - Conditions of first sexual encounter can be indicators of future HIV risk and gender-based violence
August 18, 2018 - Socio-economic position associated with pregnant women’s exposure to environmental hazards
August 18, 2018 - Study evaluates how students change their breakfast consumption when given extra time
August 18, 2018 - Chronic perinatal hypoxia linked to locomotor miscoordination, long-term cerebellar learning deficits
August 18, 2018 - Voters to settle dispute over ambulance employee break times
August 18, 2018 - AGA urges policymakers and stakeholders to improve affordability of drugs
Neuroengineering in three-dimensional brain-like microenvironments

Neuroengineering in three-dimensional brain-like microenvironments

image_pdfDownload PDFimage_print
An illustrated model compares a 2D stiff environment (left) with a 3D soft brain-like microenvironment (right) to reprogram neurons from somatic cells in the lab. Biophysical and biomechanical cues from the 3D microenvironment can boost direct neuronal reprogramming. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8

The human brain is organized of highly complex and expansive cellular and neuronal networks, but the existing scientific understanding of the developing brain is proportionately limited. Neuroengineering is an evolving field that employs advanced technology to manipulate neurons. The discipline can develop disease models of the central and peripheral nervous system to grasp neurological disorders, and produce next-generation biomaterials for neural tissue engineering. The ability to directly reprogram and convert mature cells such as fibroblasts (somatic cells) into neurons has also presented promising therapeutic potential. Technology for neuroengineering aims to design and create a broad range of applications to regulate neurons.

Neuroscientists have recently shown that brain extracellular matrix (BEM) decellularized from human brain tissue can simplify the conversion of primary mouse embryonic fibroblasts directly into induced neuronal (iN) cells in the lab. The iN cells generated on BEM substrates were transplanted in the brain of an animal model of ischemic stroke, leading to significant improvements in locomotive behaviors. The study also showed that combining 3-D BEM hydrogels with microfluidics could recreate brain-like microenvironments with higher efficacy to boost direct reprogramming and neuronal conversion, to promote functional recovery of animals after cell transplantation. The research is published in Nature Biomedical Engineering.

During neuronal reprogramming, the engineered 3-D system is believed to stimulate Yes-associated protein (YAP) and histone modifications for mechanosensitive signaling. The 3-D BEM hydrogel may also provide microenvironmental memory to retain functional phenotypes of the induced neuronal (iN) cells acquired during the conversion process. In the study, Seung-Woo Cho and co-workers first extracted brain extracellular matrix (ECM) from donor-human brain tissue to create a solubilized mixture of brain-specific native components. The solution was then used to develop and test 2-D surface coatings or 3-D systems to culture fibroblasts undergoing direct neuronal programming in the lab.

The illustrated neuroengineering procedure: decellularization of native brain tissue to produce solubilized brain extracellular matrix (BEM) to create 2D and 3D BEM platforms to reprogram fibroblasts into functional neurons. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

Direct conversion of mature somatic cells into different cell types, as seen in this instance with fibroblasts to neurons, in the presence of tissue-specific transcription factors, is known as trans-differentiation. In contrast to typical viral delivery systems, plasmids were used as the biomedical delivery vehicle of choice to transfect neuron tissue-specific elements, including BAM factors, via electroporation into the fibroblasts for induced neuronal transdifferentiation. The study showed that BEM significantly accelerated direct neuronal reprogramming, since induced neurons showed electrophysiological functions and mature neuronal marker expression as early as 14 days under laboratory conditions of cell differentiation. Immunocytochemistry and genetic analyses showed improved growth and differentiation with BEM compared to conventional biomaterials such as laminin and fibronectin, often used to fabricate 2-D extracellular matrix (ECM) coatings.

Neuroengineering in Three-dimensional Brain-like Microenvironments
Immunocytochemistry results: by day 14, the population of iN cells that stained positive for both neuron specific class III tubulin (Tuj1) and highly mature neuronal phenotype markers synapsin I (SYN1) or post synaptic density protein 95 (PSD-95) was greater in the 0.01 mg/ml BEM group than in the laminin group (LN) or in the laminin-fibronectin (LN+FN) group. DAPI (blue) stains nuclei. The region within the white box is magnified and displayed in the yellow square. BEM enhanced the direct neuronal conversion of primary fibroblasts to generate iN cells at an optimal concentration of 0.01 mg/ml. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

After completing extensive gene expression profiles and electrophysiological tests to characterize iN cells in the lab, scientists transplanted BEM-based iN cells into an adult mouse model of ischemic stroke exhibiting hypoxic brain injury to observe their therapeutic potential. In addition to neurogenesis, the paracrine effects of iN cell transplantation restored motor coordination and locomotor movement in the mice, demonstrating therapeutic efficacy.

Interestingly, cells cultured on 3-D BEM hydrogels showed higher expression levels of neuronal markers compared to 2-D BEM, indicating that biomimetic brain-like microenvironments can provide optimal biochemical and biophysical cues to guide cell reprogramming. Researchers then ingeniously combined 3-D BEM hydrogels with a microfluidic system (3-D µBEM), to amplify the autocrine and paracrine signaling of iN cells in a confined microenvironment and boost neuronal transdifferentiation.

Immunostaining analysis of iN cell cultures in multiple 3D materials, comparing conventional collagen (Col) and Matrigel (Mat) with 3D BEM, the expression of neuronal markers (Tuj1 and microtubule associated protein-2 MAP2) was significantly increased in the 3D BEM group. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

When such iN cells reprogrammed within brain-like 3-D µBEM environments were collected and transplanted in an ischemic stroke mouse model, functional recovery and therapeutic efficacy were noted. To illuminate the underlying the molecular mechanisms, scientists proposed that biophysical cues in a 3-D brain-like microenvironment may specifically induce YAP (Yes-associated protein) localization to the cellular cytoplasm to promote neuronal transdifferentiation. In contrast, stiff 2-D environments induced nuclear YAP localization, repressing neurogenesis-related gene expression, as observed in the study.

Understanding the molecular mechanisms of direct neural reprogramming for implantation in an animal model of ischemic stroke: a) immunostaining YAP (green) to quantify YAP localization in 2D and 3D conditions, b) tracking Dil-labelled (red, long-term tracer of neurons) iN cells generated from 3D µBEM at day 7 after cell injection in the striatum and cortex within the ischemic brain of an animal model. Credit: Nature Biomedical Engineering, doi: 10.1038/s41551-018-0260-8.

The study sheds light on the molecular mechanisms underlying direct neurogenesis, together with strategies to design and develop optimized biomaterials for improved neural reprogramming, reproducible in the lab. Brain-like 3-D biomimetic microenvironments can provide biochemical, biophysical, mechanical and epigenetic stimuli to efficiently reprogram neurons. Key insights from the study can be translated in the future to design and engineer a synthetic brain-like matrix to generate safe iN cells for regenerative and medical applications in neuroengineering.


Explore further:
Direct conversion of non-neuronal cells into nerve cells

More information:
Three-dimensional brain-like microenvironments facilitate the direct reprogramming of fibroblasts into therapeutic neurons www.nature.com/articles/s41551-018-0260-8 Jin et al, 11 July 2018, Nature Biomedical Engineering.

Liver extracellular matrix providing dual functions of two-dimensional substrate coating and three-dimensional injectable hydrogel platform for liver tissue engineering pubs.acs.org/doi/10.1021/bm4015039 Lee et al, 2014, Biomacromolecules.

Heart repair by reprogramming non-myocytes with cardiac transcription factors www.ncbi.nlm.nih.gov/pmc/articles/PMC3367390/ Song et al, 2012, Nature.

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes www.ncbi.nlm.nih.gov/pmc/articles/PMC3369107/ Qian et al, 2012, Nature.

High-efficiency cellular reprogramming with microfluidics www.nature.com/articles/nmeth.3832 Luni et al, 2016, Nature Methods.

Biophysical regulation of epigenetic state and cell reprogramming www.nature.com/articles/nmat3777 Downing et al, 2013, Nature Materials.

3-D niche microarrays for systems-level analyses of cell fate www.nature.com/articles/ncomms5324 Ranga et al, 2014, Nature Communications.

Substratum-induced differentiation of human pluripotent stem cells reveals the coactivator YAP is a potent regulator of neuronal specification www.pnas.org/content/111/38/13805 Musah et al, 2014, Proceedings of the National Academy of Sciences.

Tagged with:

About author

Related Articles